In this episode of the Newcomer podcast, Eric Newcomer and Nayeema Raza recap their inaugural AI Health and Longevity Summit, Deus Ex Medicina, highlighting key themes and discussions. They delve into the Trump administration's healthcare policies, the rivalry between AI companies like Abridge and Open Evidence, and the potential for pharmaceutical companies to invest in longevity treatments, drawing insights from interviews with industry leaders. The conversation also covers the role of wearable technology in health monitoring, debates around foundational models in healthcare AI, and the future of healthcare subscriptions and bundled services.
Outlines
Sign in to continue reading, translating and more.
Open full episode in Podwise